OBJECTIVES: For large scale follow up studies with non-demented patients in which cognition is an endpoint, there is a need for short, inexpensive, sensitive, and reliable neuropsychological tests that are suitable for repeated measurements. The commonly used Mini-Mental-State-Examination fulfils only the first two requirements. METHODS: In the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER), 5804 elderly subjects aged 70 to 82 years were examined using a learning test (memory), a coding test (general speed), and a short version of the Stroop test (attention). Data presented here were collected at dual baseline, before randomisation for active treatment. RESULTS: The tests proved to be reliable (with test/retest reliabilities ranging from acceptable (r=0.63) to high (r=0.88) and sensitive to detect small differences in subjects from different age categories. All tests showed significant practice effects: performance increased from the first measurement to the first follow up after two weeks. CONCLUSION: Normative data are provided that can be used for one time neuropsychological testing as well as for assessing individual and group change. Methods for analysing cognitive change are proposed.
RCT Entities:
OBJECTIVES: For large scale follow up studies with non-demented patients in which cognition is an endpoint, there is a need for short, inexpensive, sensitive, and reliable neuropsychological tests that are suitable for repeated measurements. The commonly used Mini-Mental-State-Examination fulfils only the first two requirements. METHODS: In the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER), 5804 elderly subjects aged 70 to 82 years were examined using a learning test (memory), a coding test (general speed), and a short version of the Stroop test (attention). Data presented here were collected at dual baseline, before randomisation for active treatment. RESULTS: The tests proved to be reliable (with test/retest reliabilities ranging from acceptable (r=0.63) to high (r=0.88) and sensitive to detect small differences in subjects from different age categories. All tests showed significant practice effects: performance increased from the first measurement to the first follow up after two weeks. CONCLUSION: Normative data are provided that can be used for one time neuropsychological testing as well as for assessing individual and group change. Methods for analysing cognitive change are proposed.
Authors: J Shepherd; G J Blauw; M B Murphy; S M Cobbe; E L Bollen; B M Buckley; I Ford; J W Jukema; M Hyland; A Gaw; A M Lagaay; I J Perry; P W Macfarlane; A E Meinders; B J Sweeney; C J Packard; R G Westendorp; C Twomey; D J Stott Journal: Am J Cardiol Date: 1999-11-15 Impact factor: 2.778
Authors: J T Moller; P Cluitmans; L S Rasmussen; P Houx; H Rasmussen; J Canet; P Rabbitt; J Jolles; K Larsen; C D Hanning; O Langeron; T Johnson; P M Lauven; P A Kristensen; A Biedler; H van Beem; O Fraidakis; J H Silverstein; J E Beneken; J S Gravenstein Journal: Lancet Date: 1998-03-21 Impact factor: 79.321
Authors: D M J van den Heuvel; V H ten Dam; A J M de Craen; F Admiraal-Behloul; H Olofsen; E L E M Bollen; J Jolles; H M Murray; G J Blauw; R G J Westendorp; M A van Buchem Journal: J Neurol Neurosurg Psychiatry Date: 2006-02 Impact factor: 10.154
Authors: Martin Feller; Marieke Snel; Elisavet Moutzouri; Douglas C Bauer; Maria de Montmollin; Drahomir Aujesky; Ian Ford; Jacobijn Gussekloo; Patricia M Kearney; Simon Mooijaart; Terry Quinn; David Stott; Rudi Westendorp; Nicolas Rodondi; Olaf M Dekkers Journal: JAMA Date: 2018-10-02 Impact factor: 56.272
Authors: D A Bennett; I J Deary; M A Ikram; L J Launer; A L Fitzpatrick; S Seshadri; C M van Duijn; T H Mosley; C A Ibrahim-Verbaas; J Bressler; S Debette; M Schuur; A V Smith; J C Bis; G Davies; S Trompet; J A Smith; C Wolf; L B Chibnik; Y Liu; V Vitart; M Kirin; K Petrovic; O Polasek; L Zgaga; C Fawns-Ritchie; P Hoffmann; J Karjalainen; J Lahti; D J Llewellyn; C O Schmidt; K A Mather; V Chouraki; Q Sun; S M Resnick; L M Rose; C Oldmeadow; M Stewart; B H Smith; V Gudnason; Q Yang; S S Mirza; J W Jukema; P L deJager; T B Harris; D C Liewald; N Amin; L H Coker; O Stegle; O L Lopez; R Schmidt; A Teumer; I Ford; N Karbalai; J T Becker; M K Jonsdottir; R Au; Rsn Fehrmann; S Herms; M Nalls; W Zhao; S T Turner; K Yaffe; K Lohman; J C van Swieten; Slr Kardia; D S Knopman; W M Meeks; G Heiss; E G Holliday; P W Schofield; T Tanaka; D J Stott; J Wang; P Ridker; A J Gow; A Pattie; J M Starr; L J Hocking; N J Armstrong; S McLachlan; J M Shulman; L C Pilling; G Eiriksdottir; R J Scott; N A Kochan; A Palotie; Y-C Hsieh; J G Eriksson; A Penman; R F Gottesman; B A Oostra; L Yu; A L DeStefano; A Beiser; M Garcia; J I Rotter; M M Nöthen; A Hofman; P E Slagboom; Rgj Westendorp; B M Buckley; P A Wolf; A G Uitterlinden; B M Psaty; H J Grabe; S Bandinelli; D I Chasman; F Grodstein; K Räikkönen; J-C Lambert; D J Porteous; J F Price; P S Sachdev; L Ferrucci; J R Attia; I Rudan; C Hayward; A F Wright; J F Wilson; S Cichon; L Franke; H Schmidt; J Ding; Ajm de Craen; M Fornage Journal: Mol Psychiatry Date: 2015-04-14 Impact factor: 15.992
Authors: Sjoerd M Euser; Naveed Sattar; Jacqueline C M Witteman; Eduard L E M Bollen; Eric J G Sijbrands; Albert Hofman; Ivan J Perry; Monique M B Breteler; Rudi G J Westendorp Journal: Diabetes Date: 2010-04-14 Impact factor: 9.461
Authors: Fiona Taylor; Mark D Huffman; Ana Filipa Macedo; Theresa H M Moore; Margaret Burke; George Davey Smith; Kirsten Ward; Shah Ebrahim Journal: Cochrane Database Syst Rev Date: 2013-01-31